The Liang group studies molecular systems medicine. 

The current work in our group focuses on three areas: (epi)genomics and precision medicine, regulatory RNA, and cellular metabolism, as they relate to hypertension and cardiovascular and kidney diseases. 

We have a multidisciplinary, translational research platform where we integrate human research with animal, induced pluripotent stem cell (iPSC), and other model system research using approaches of physiology, multi-omics, single-cell and spatial omics, big data analysis, genome editing, genetics, biochemistry, and molecular and cell biology.

The Liang group is part of the Department of Physiology at the University of Arizona College of Medicine – Tucson.